PortfoliosLab logoPortfoliosLab logo
SMRI vs. RNIN
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

SMRI vs. RNIN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bushido Capital US Equity ETF (SMRI) and Bushido Capital US SMID Cap Equity ETF (RNIN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SMRI achieves a 13.23% return, which is significantly lower than RNIN's 14.72% return.


SMRI

1D
0.19%
1M
1.93%
YTD
13.23%
6M
11.81%
1Y
27.78%
3Y*
5Y*
10Y*

RNIN

1D
-0.01%
1M
0.64%
YTD
14.72%
6M
13.13%
1Y
27.51%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

SMRI vs. RNIN - Yearly Performance Comparison


2026 (YTD)2025
SMRI
Bushido Capital US Equity ETF
13.23%15.44%
RNIN
Bushido Capital US SMID Cap Equity ETF
14.72%10.92%

Correlation

The correlation between SMRI and RNIN is 0.84, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.84

Correlation (All Time)
Calculated using the full available price history since May 15, 2025

0.85

The correlation between SMRI and RNIN has been stable across timeframes, ranging from 0.84 to 0.85 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SMRI vs. RNIN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SMRI
SMRI Risk / Return Rank: 6262
Overall Rank
SMRI Sharpe Ratio Rank: 5555
Sharpe Ratio Rank
SMRI Sortino Ratio Rank: 5656
Sortino Ratio Rank
SMRI Omega Ratio Rank: 5454
Omega Ratio Rank
SMRI Calmar Ratio Rank: 8181
Calmar Ratio Rank
SMRI Martin Ratio Rank: 6666
Martin Ratio Rank

RNIN
RNIN Risk / Return Rank: 6868
Overall Rank
RNIN Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
RNIN Sortino Ratio Rank: 5858
Sortino Ratio Rank
RNIN Omega Ratio Rank: 5454
Omega Ratio Rank
RNIN Calmar Ratio Rank: 8787
Calmar Ratio Rank
RNIN Martin Ratio Rank: 8383
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SMRI vs. RNIN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bushido Capital US Equity ETF (SMRI) and Bushido Capital US SMID Cap Equity ETF (RNIN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SMRIRNINDifference
Sharpe ratioReturn per unit of total volatility

-0.01

Sortino ratioReturn per unit of downside risk

-0.08

Omega ratioGain probability vs. loss probability

1.33

1.32

0.00

Calmar ratioReturn relative to maximum drawdown

4.10

4.85

-0.75

Martin ratioReturn relative to average drawdown

11.83

16.24

-4.41

SMRI vs. RNIN - Sharpe Ratio Comparison

The current SMRI Sharpe Ratio is 1.83, which is comparable to the RNIN Sharpe Ratio of 1.85. The chart below compares the historical Sharpe Ratios of SMRI and RNIN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SMRI vs. RNIN - Drawdown Comparison

The maximum SMRI drawdown since its inception was -18.45%, which is greater than RNIN's maximum drawdown of -5.70%. Use the drawdown chart below to compare losses from any high point for SMRI and RNIN.


Loading charts...

Drawdown Indicators


SMRIRNINDifference

Max Drawdown

Largest peak-to-trough decline

-18.45%

-5.70%

-12.75%

Max Drawdown (1Y)

Largest decline over 1 year

-6.80%

-5.70%

-1.10%

Current Drawdown

Current decline from peak

-5.63%

-3.56%

-2.07%

Average Drawdown

Average peak-to-trough decline

-2.73%

-1.29%

-1.44%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.35%

1.70%

+0.65%

Volatility

SMRI vs. RNIN - Volatility Comparison

Bushido Capital US Equity ETF (SMRI) has a higher volatility of 7.18% compared to Bushido Capital US SMID Cap Equity ETF (RNIN) at 4.83%. This indicates that SMRI's price experiences larger fluctuations and is considered to be riskier than RNIN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SMRIRNINDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.18%

4.83%

+2.35%

Volatility (6M)

Calculated over the trailing 6-month period

11.71%

10.63%

+1.08%

Volatility (1Y)

Calculated over the trailing 1-year period

15.25%

15.01%

+0.24%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

15.96%

14.91%

+1.05%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

15.96%

14.91%

+1.05%

SMRI vs. RNIN - Expense Ratio Comparison

SMRI has a 0.71% expense ratio, which is higher than RNIN's 0.68% expense ratio.


Dividends

SMRI vs. RNIN - Dividend Comparison

SMRI's dividend yield for the trailing twelve months is around 0.99%, more than RNIN's 0.77% yield.


PositionTTM202520242023
RNIN
Bushido Capital US SMID Cap Equity ETF
0.77%0.71%0.00%0.00%
SMRI
Bushido Capital US Equity ETF
0.99%1.32%0.98%0.45%

Frequently Asked Questions


SMRI and RNIN have a correlation of 0.84, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SMRI has higher volatility (7.18%) compared to RNIN (4.83%). In terms of maximum drawdown, SMRI dropped -18.45% vs RNIN's -5.70%.

On 1-year performance, SMRI leads with 27.78% vs 27.51% for RNIN. On fees, RNIN is cheaper at 0.68% per year. On volatility, RNIN has been the lower-risk option at 4.83%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, SMRI has performed better with a 27.78% return vs 27.51%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

RNIN is cheaper with a 0.68% expense ratio, compared with 0.71% for SMRI.

SMRI has the higher dividend yield at 0.99%, compared with 0.77% for RNIN.

SMRI is categorized as Large Cap Value Equities, while RNIN is Mid Cap Value Equities. Their fees differ too: 0.71% for SMRI and 0.68% for RNIN.

RNIN currently has the higher Sharpe Ratio (1.85 vs 1.83), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SMRI and RNIN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer